Takashi Fukushima

A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?

K. Yoneyama, S. Iida, H. Yoshitsugu, 2014, Journal of clinical pharmacology.

Different truncation methods of AUC between Japan and the EU for bioequivalence assessment: influence on the regulatory judgment.

M. Oishi, Y. Tomono, T. Suwa, 2012, Drug metabolism and pharmacokinetics.

Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report

S. Tasaka, Hisashi Tanaka, K. Taima, 2022, Thoracic cancer.